Nabi Biopharmaceuticals Appoints Matthew W. Kalnik, Ph.D., as Vice President, Business Development and Project Management Jul 13, 2007
Prior to VistaGen, he held senior management team positions and led business development efforts at Genaissance Pharmaceuticals, Pharmacia, Pfizer and Daiichi Medical Research. Dr. Kalnik also founded Hedgerow Consulting and has authored more than a dozen primary research papers. (PR Newswire)
Clinical Data's Cogenics Division Enters Into Alliance with Epigenomics for DNA Methylation Services Apr 12, 2007
D., Senior Vice President and General Manager of Cogenics, said, "We are very pleased to enter into this partnership agreement with Epigenomics and look forward to working closely with the company. We are excited to offer Cogenics customers Epigenomics expertise and technology in DNA methylation services. This partnership brings unique value to our customers by expanding our current biomarker offering to now allow them to use DNA methylation as a marker of disease diagnosis, prognosis and drug... (BusinessWire)
'Beware' online DNA testing (Christine Simmons) Jul 28, 2006
"By understanding genetic variation and its relationship to drug response, it is possible to determine which individuals are most likely to benefit from a given drug, even before the drug is prescribed," said Carol Reed, chief medical officer for Genaissance Pharmaceuticals in Newton, Mass. But administrators and laboratory officials said they favor more regulation for genetic testing. (Washington Times)
Biotech booms in Elm City, study concludes Apr 11, 2006
Major biotech companies in the city, many of which are located in Science Park at 300 George St., include Genaissance Pharmaceuticals and CuraGen Corp.. 1995-2006 Yale Daily News Publishing Company, Inc. All rights reserved. (Yale Daily News, CT)
Amphion Innovations plc Preliminary Results Show 24% Increase In... Mar 8, 2006
Motif has hired Dr. Kevin Arnold, formerly the Executive Director of Operations of Genaissance Pharmaceuticals, who now serves as the Executive Director of Genomic Operations at Motif. Manish Pungliya, formerly a Bioinformatics Scientist at Genaissance Pharmaceuticals, has been hired to lead Motif's bioinformatics effort. (CNBC -- Research Alerts)
Clinical Data pays $3M for French firm Mar 8, 2006
rival Genaissance Pharmaceuticals; $11. 5 million for Icoria of Research Triangle Park, N.C.; and $1. (Boston Business Journal, MA)
Recently purchased Icoria moving out of RTP Jan 10, 2006
In 2005 Clinical Data also acquired Genaissance, a Morrisville genomics company with more than 100 employees. Mark Shooman, Clinical Data's chief financial officer, said the operations of Icoria and Genaissance will be consolidated in one location in Perimeter Park in Morrisville ... The acquisitions of Icoria and Genaissance signal the company's intention to focus on pharmacogenomics -- the field that looks at the interaction between a person's genetic makeup and his or her response to... (Herald Sun)
